Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. （開啟新視窗）

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

來源‎: Crit Care Med 2009;37(4):1299-307.

檢索‎: PubMed 19242343

DOI碼‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 （開啟新視窗）

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. （開啟新視窗）

Ball AM, Winstead PS.

來源‎: Pharmacotherapy 2008;28(11):1383-90.

檢索‎: PubMed 18956998

DOI碼‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 （開啟新視窗）

Reducing postburn injury anemia in a Jehovah's Witness patient. （開啟新視窗）

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

來源‎: J Burn Care Res 2014;35(4):e258-61.

檢索‎: PubMed 24121804

DOI碼‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 （開啟新視窗）

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. （開啟新視窗）

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

來源‎: Clin Ther 2008;30(12):2324-34.

檢索‎: PubMed 19167591

DOI碼‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 （開啟新視窗）

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. （開啟新視窗）

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

來源‎: Transplant Proc 2015;47(8):2548-51.

檢索‎: PubMed 26518969

DOI碼‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 （開啟新視窗）

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. （開啟新視窗）

Charles A, Purtill M, Napolitano LM.

來源‎: Anaesth Intensive Care 2006;34(6):793-6.

檢索‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 （開啟新視窗）

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. （開啟新視窗）

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

來源‎: Crit Care Med 1999;27(11):2346-50.

檢索‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 （開啟新視窗）

Erythropoietin for critically ill trauma patients: a missed opportunity? （開啟新視窗）

Corwin HL, Napolitano LM

來源‎: J Trauma Acute Care Surg 2014;77(5):774-9.

檢索‎: PubMed 25494432

DOI碼‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 （開啟新視窗）

Postoperative management of severe acute anemia in a Jehovah's Witness. （開啟新視窗）

de Araújo Azi LM, Lopes FM, Garcia LV

來源‎: Transfusion 2014;54(4):1153-7.

檢索‎: PubMed 24117834

DOI碼‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 （開啟新視窗）

Restrictive transfusion in geriatric trauma patients. （開啟新視窗）

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

來源‎: Am Surg 2016;82(1):85-8.

檢索‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 （開啟新視窗）

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. （開啟新視窗）

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

來源‎: J Trauma 1998;44(2):361-7.

檢索‎: PubMed 9498512

DOI碼‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 （開啟新視窗）

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. （開啟新視窗）

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

來源‎: Crit Care 2005;9(5):R508-15.

檢索‎: PubMed 16277712

DOI碼‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 （開啟新視窗）

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. （開啟新視窗）

Hong T, Shander A, Agarwal S, Castresana M.

來源‎: A A Case Rep 2015;4(10):127-31.

檢索‎: PubMed 25974416

DOI碼‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 （開啟新視窗）

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. （開啟新視窗）

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

來源‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

檢索‎: PubMed 35941026

DOI碼‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ （開啟新視窗）

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. （開啟新視窗）

Lindholm J, Palmér K, Frenckner B.

來源‎: Perfusion 2012;27(4):332-4.

檢索‎: PubMed 22496111

DOI碼‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 （開啟新視窗）

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. （開啟新視窗）

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

來源‎: Am Surg 2010;76(9):951-6.

檢索‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 （開啟新視窗）

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. （開啟新視窗）

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

來源‎: Intensive Care Med 2013;39(11):1896-908.

檢索‎: PubMed 23928897

DOI碼‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 （開啟新視窗）

Transfusion-free treatment strategies for acute anemia in critical care. （開啟新視窗）

Morgan CA, Byul Sarah S, Forest CP.

來源‎: JAAPA 2016;29(8):38-44.

檢索‎: PubMed 27467297

DOI碼‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 （開啟新視窗）

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. （開啟新視窗）

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

來源‎: J Trauma 2008;65(2):285-97.

檢索‎: PubMed 18695463

DOI碼‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 （開啟新視窗）

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. （開啟新視窗）

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

來源‎: J Trauma 2009;67(1):121-4.

檢索‎: PubMed 19590320

DOI碼‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 （開啟新視窗）

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. （開啟新視窗）

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

來源‎: Surg Infect (Larchmt) 2009;10(1):9-19.

檢索‎: PubMed 19245362

DOI碼‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 （開啟新視窗）

How do we treat life-threatening anemia in a Jehovah's Witness patient? （開啟新視窗）

Posluszny JA Jr, Napolitano LM.

來源‎: Transfusion 2014;54(12):3026-34.

檢索‎: PubMed 25330835

DOI碼‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 （開啟新視窗）

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. （開啟新視窗）

Price S, Pepper JR, Jaggar SI.

來源‎: Anesth Analg 2005;101(2):325-7.

檢索‎: PubMed 16037136

DOI碼‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 （開啟新視窗）

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. （開啟新視窗）

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

來源‎: Am Surg 2015;81(6):e263-5.

檢索‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 （開啟新視窗）

Erythropoietin response is blunted in critically ill patients. （開啟新視窗）

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

來源‎: Intensive Care Med 1997;23(2):159-62.

檢索‎: PubMed 9069000

DOI碼‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 （開啟新視窗）

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. （開啟新視窗）

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

來源‎: Br J Anaesth 2005;94(4):442-4.

檢索‎: PubMed 15653706

DOI碼‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 （開啟新視窗）

Management of anemia in patients who decline blood transfusion. （開啟新視窗）

Shander A, Goodnough LT

來源‎: Am J Hematol 2018;93(9):1183-91.

檢索‎: PubMed 30033541

DOI碼‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ （開啟新視窗）

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. （開啟新視窗）

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

來源‎: Arch Surg 2012;147(3):251-5.

檢索‎: PubMed 22430906

DOI碼‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 （開啟新視窗）

Intravenous iron following cardiac surgery does not increase the infection rate. （開啟新視窗）

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

來源‎: Surg Infect (Larchmt) 2006;7(4):361-6.

檢索‎: PubMed 16978079

DOI碼‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 （開啟新視窗）

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. （開啟新視窗）

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

來源‎: Crit Care 2015;19:49.

檢索‎: PubMed 25888250

DOI碼‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 （開啟新視窗）

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. （開啟新視窗）

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

來源‎: Crit Care Med 2024;52(4):618-25.

檢索‎: PubMed 37962159

DOI碼‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ （開啟新視窗）